Top Artificial Intelligence-Based Healthcare Mobile Apps and Their Use Cases

Articles

Promising Nephrotic Syndrome Treatments: A Look...

Nephrotic syndrome is a clinical condition characterized by significant protein in the urine (exceeding 40 mg/m2/h), leading to low levels of albumin (below 30 g/L), which in turn causes high level...

Mar 18, 2024

trop2-inhibitors-for-cancer-treatment
Unveiling the Potential of TROP-2 Inhibitors: A New Frontier in Cancer Treatment

Trophoblast cell surface antigen-2 (TROP-2) is a 35-kDa protein found on cell membranes, made of sugars and a protein chain, serving as a transmitter of calcium signals. It is produced by the TACSTD2 gene and shares a structural similarity with the epithelial cell adhesion molecule (EpCAM). TROP2, although ident...

Find More
Telemedicine Service
Telemedicine Service: Delving into Opportunities and Key Growth Factors Driving Market

Telemedicine Services have emerged as a transformative force in healthcare delivery, offering remote diagnosis, consultation, and treatment through telecommunications technology. This innovative approach to healthcare has garnered significant attention due to its potential to address various challenges plaguing tra...

Find More
giant-cell-arteritis-treatment-therapies
Giant-Cell Arteritis Treatment Beyond Glucocorticoids: Exploring Horizons

Giant-cell arteritis (GCA), alternatively referred to as temporal arteritis, is a form of vasculitis primarily impacting arteries, particularly those in proximity to the temples. If left untreated, it may result in notable complications such as loss of vision. Diagnosis of the disease is often complicated by its pr...

Find More

More Views & Analysis

emerging-therapies-for-alport-syndrome-treatment
Breakthroughs in Alport Syndrome Treatment: A New Era of Hope

Alport syndrome, an inherited disease, predominantly manifests in its X-linked form, constituting around 80% of cases. Without intervention, roughly 90% of affected males face kidney failure by age 40, whereas females typically experience a slower progression to this condition. Many Alport syndrome cases go unnotic...

Find More

Nicotine Replacement Therapy Market Insights
How Innovations Are Driving the Growth of the Nicotine Replacement Therapy Market?

The Nicotine Replacement Therapy (NRT) market is experiencing a notable evolution driven by a confluence of factors, including shifting societal attitudes towards smoking cessation, heightened awareness of the health risks associated with tobacco use, and an increasing emphasis on promoting public health initiative...

Find More

gene-therapies-in-ophthalmology
Gene Therapies as a Game-Changer in Ophthalmology: Eyeing the Future

Gene therapy is becoming a promising solution for retinal degenerative illnesses, particularly because the retina offers an excellent avenue for studying and treating eye-related issues. Importantly, it is the first tissue in the United States to receive approval for gene therapy in cases of inherited disorders. ...

Find More

xolair-for-food-allergy-treatment
Revolutionizing the Food Allergy Treatment: The Impact of Xolair’s Approval

Individuals suffering from food allergies now have access to a medication that can potentially avert serious consequences. This medication, which has been available for twenty years, has received approval from the FDA. Xolair (omalizumab) by Roche and Novartis is the first food allergy treatment sanctioned to dimin...

Find More

Pharmacy Automation Systems Market Insights
Navigating the Evolving Landscape of Pharmacy Automation Solutions

Pharmacy Automation Systems represent a pivotal advancement in healthcare technology, revolutionizing the way medications are dispensed, managed, and administered. Over the years, these systems have evolved from rudimentary pill counters to sophisticated robotic dispensers and integrated software platforms. Moreove...

Find More

amtagvi-in-solid-tumors
Iovance’s Breakthrough: Amtagvi Paves the Way for Cell Therapies in Solid Tumors

The category of T-cell therapy, which revolutionized the management of specific blood cancers, has now extended its impact to solid tumor treatment with the approval from the FDA of a groundbreaking immunotherapy pioneered by Iovance Biotherapeutics. Known as Amtagvi or lifileucel, this medication marks the debut o...

Find More

In the past few years, online buying has become the easiest way to purchase products and services. T.....

Find More

Sepsis is a life-threatening organ dysfunction caused by dysregulated host response to infection. Se.....

Find More

Scleroderma is a chronic disease that affects the skin, the connective tissue that supports and hold.....

Find More

Affecting the entire body, Adult Onset Still's disease (AOSD) is a rare type of inflammatory arthrit.....

Find More

Though Covid-19 has a significant impact on the supply chain, input costs, logistics, and raw materi.....

Find More

Lupus Nephritis (LN) is one of the most common manifestations of systemic lupus erythematosus (SLE),.....

Find More